Loading...
Loading...
Advanced Biomed Inc.
Advanced Biomed Inc.. Spoken Alpha tracks ADVB's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks ADVB's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 80% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ADVB.
curl https://api.spokenalpha.com/v1/companies/ADVB| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.19 | $3.65 | +14.8% | -4.9% | -2.8% |
| Q4 FY2026 | $4.25 | $3.54 | +20.0% | -1.0% | +0.9% |
| Q3 FY2026 | $4.20 | $3.53 | +19.0% | -3.0% | -4.3% |
| Q2 FY2026 | $4.30 | $3.50 | +23.0% | +2.8% | +3.0% |
| Q1 FY2025 | $4.74 | $3.74 | +26.8% | -0.1% | +1.3% |
| Q4 FY2025 | $4.53 | $3.78 | +19.8% | -2.8% | -0.1% |
| Q3 FY2025 | $4.03 | $3.53 | +14.3% | -1.6% | +0.2% |
| Q2 FY2025 | $4.42 | $3.62 | +22.1% | -4.2% | -1.4% |
| Q1 FY2024 | $4.50 | $3.80 | +18.4% | +1.2% | +3.5% |
| Q4 FY2024 | $4.64 | $3.84 | +20.8% | -3.9% | -6.8% |